TY - JOUR AU - Okamoto, H. AU - Mineta, T. AU - Nakahara, Y. AU - Ichinose, M. AU - Shiraishi, T. AU - Tabuchi, K. PY - 2004 DA - 2004// TI - Molecular analysis of astrocytoma associated with Turcot syndrome type 1--case report JO - Neurol Med Chir (Tokyo) VL - 44 UR - https://doi.org/10.2176/nmc.44.124 DO - 10.2176/nmc.44.124 ID - Okamoto2004 ER - TY - JOUR AU - Itoh, H. AU - Ohsato, K. PY - 1985 DA - 1985// TI - Turcot syndrome and its characteristic colonic manifestations JO - Dis Colon Rectum VL - 28 UR - https://doi.org/10.1007/BF02560221 DO - 10.1007/BF02560221 ID - Itoh1985 ER - TY - JOUR AU - Shia, J. PY - 2008 DA - 2008// TI - Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. the utility of immunohistochemistry JO - J Mol Diagnostics VL - 10 UR - https://doi.org/10.2353/jmoldx.2008.080031 DO - 10.2353/jmoldx.2008.080031 ID - Shia2008 ER - TY - JOUR AU - Barrow, E. AU - Hill, J. AU - Gareth, E. D. PY - 2013 DA - 2013// TI - Cancer risk in lynch syndrome JO - Familial Cancer VL - 12 UR - https://doi.org/10.1007/s10689-013-9615-1 DO - 10.1007/s10689-013-9615-1 ID - Barrow2013 ER - TY - JOUR AU - Masuda, K. AU - Banno, K. AU - Yanokura, M. PY - 2011 DA - 2011// TI - Relationship between DNA mismatch repair deficiency and endometrial Cancer JO - Mol Biol Int VL - 2011 UR - https://doi.org/10.4061/2011/256063 DO - 10.4061/2011/256063 ID - Masuda2011 ER - TY - JOUR AU - Peltomäki, P. PY - 2003 DA - 2003// TI - Role of DNA mismatch repair defects in the pathogenesis of human cancer JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.04.060 DO - 10.1200/JCO.2003.04.060 ID - Peltomäki2003 ER - TY - JOUR AU - Boland, C. R. AU - Goel, A. PY - 2010 DA - 2010// TI - Microsatellite Instability in Colorectal Cancer JO - Gastroenterology VL - 138 UR - https://doi.org/10.1053/j.gastro.2009.12.064 DO - 10.1053/j.gastro.2009.12.064 ID - Boland2010 ER - TY - JOUR AU - Shia, J. AU - Zhang, L. AU - Shike, M. PY - 2014 DA - 2014// TI - Secondary mutation in a coding mononucleotide tract in MSH6 causes loss of immunoexpression of MSH6 in colorectal carcinomas with MLH1/PMS2 deficiency JO - Mod Pathol VL - 26 UR - https://doi.org/10.1038/modpathol.2012.138 DO - 10.1038/modpathol.2012.138 ID - Shia2014 ER - TY - JOUR AU - Hamilton, S. R. AU - Liu, B. AU - Parsons, R. E. AU - Papadopoulos, N. AU - Jen, J. PY - 2014 DA - 2014// TI - The molecular basis of turcot’s syndrome JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199503303321302 DO - 10.1056/NEJM199503303321302 ID - Hamilton2014 ER - TY - JOUR AU - Peltomäki, P. V. H. PY - 2004 DA - 2004// TI - Mutations associated with HNPCC predisposition – update of ICG-HNPCC / INSiGHT mutation database JO - Dis Markers VL - 20 UR - https://doi.org/10.1155/2004/305058 DO - 10.1155/2004/305058 ID - Peltomäki2004 ER - TY - JOUR AU - Tanakaya, K. PY - 2018 DA - 2018// TI - Current clinical topics of lynch syndrome JO - Int J Clin Oncol VL - 0 ID - Tanakaya2018 ER - TY - JOUR AU - Hinoi, T. AU - Tani, M. AU - Lucas, P. C. PY - 2001 DA - 2001// TI - Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the Colon JO - Am J Pathol VL - 159 UR - https://doi.org/10.1016/S0002-9440(10)63074-X DO - 10.1016/S0002-9440(10)63074-X ID - Hinoi2001 ER - TY - JOUR AU - Hinoi, T. AU - Loda, M. AU - Fearon, E. R. PY - 2003 DA - 2003// TI - Silencing of CDX2 expression in Colon Cancer via a dominant repression pathway JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M307435200 DO - 10.1074/jbc.M307435200 ID - Hinoi2003 ER - TY - JOUR AU - Duval, A. AU - Hamelin, R. PY - 2002 DA - 2002// TI - Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability JO - Cancer Res VL - 62 ID - Duval2002 ER - TY - JOUR AU - Ohmiya, N. AU - Matsumoto, S. AU - Yamamoto, H. AU - Baranovskaya, S. AU - Malkhosyan, S. R. AU - Perucho, M. PY - 2001 DA - 2001// TI - Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype JO - Gene. VL - 272 UR - https://doi.org/10.1016/S0378-1119(01)00517-0 DO - 10.1016/S0378-1119(01)00517-0 ID - Ohmiya2001 ER - TY - JOUR AU - Felix, A. AU - Rosa, E. PY - 2015 DA - 2015// TI - Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas JO - Am J Surg Pathol VL - 39 UR - https://doi.org/10.1097/PAS.0000000000000459 DO - 10.1097/PAS.0000000000000459 ID - Felix2015 ER - TY - JOUR AU - Martinez, R. AU - Schackert, H. K. AU - Plaschke, J. AU - Baretton, G. AU - Appelt, H. AU - Schackert, G. PY - 2004 DA - 2004// TI - Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme JO - Oncology. VL - 66 UR - https://doi.org/10.1159/000079488 DO - 10.1159/000079488 ID - Martinez2004 ER - TY - JOUR AU - Ribic, C. M. AU - Sargent, D. J. AU - Moore, M. J. PY - 2003 DA - 2003// TI - Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for Colon Cancer JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa022289 DO - 10.1056/NEJMoa022289 ID - Ribic2003 ER - TY - JOUR AU - Longley, D. B. AU - Harkin, D. P. AU - Johnston, P. G. PY - 2003 DA - 2003// TI - 5-fluorouracil: mechanisms of action and clinical strategies JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1074 DO - 10.1038/nrc1074 ID - Longley2003 ER - TY - JOUR AU - André, T. AU - Gramont, A. AU - Vernerey, D. PY - 2015 DA - 2015// TI - Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.63.4238 DO - 10.1200/JCO.2015.63.4238 ID - André2015 ER - TY - JOUR AU - Zaanan, A. AU - Shi, Q. AU - Taieb, J. PY - 2018 DA - 2018// TI - Role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy a pooled analysis from 2 randomized clinical trials JO - JAMA Oncol VL - 4 UR - https://doi.org/10.1001/jamaoncol.2017.2899 DO - 10.1001/jamaoncol.2017.2899 ID - Zaanan2018 ER - TY - JOUR AU - Sargent, D. J. AU - Marsoni, S. AU - Monges, G. PY - 2010 DA - 2010// TI - Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.1825 DO - 10.1200/JCO.2009.27.1825 ID - Sargent2010 ER - TY - JOUR AU - Le, D. T. AU - Durham, J. N. AU - Smith, K. N. AU - Wang, H. AU - Bartlett, B. R. AU - Laveet, K. A. AU - Lu, S. AU - Kemberling, H. AU - Wilt, C. AU - Luber, B. S. AU - Wong, F. AU - Nilofer, S. PY - 2017 DA - 2017// TI - Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade JO - Science. VL - 6733 UR - https://doi.org/10.1126/science.aan6733 DO - 10.1126/science.aan6733 ID - Le2017 ER -